Amicus Therapeutics Inc (FRA:AM6)
€ 9.3 0.2 (2.2%) Market Cap: 2.82 Bil Enterprise Value: 3.01 Bil PE Ratio: 0 PB Ratio: 16.43 GF Score: 78/100

Amicus Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) Transcript

Nov 09, 2020 / 01:00PM GMT
Release Date Price: €17.2 (-2.82%)
Martin Douglas Auster;dit Suisse AG
CrÃ;Research Division - Research Analyst

© -

I think we're live now, yes. Well, welcome to everyone who's joining us today. We're going to kick off the Credit Suisse 29th Annual Virtual -- well, first-ever virtual healthcare conference, 29th annual conference. I've got John Crowley; and Andrew Faughnan from Amicus Therapeutics to do a presentation. We have time for a few questions at the end. If anybody has any questions in the audience, please e-mail them over to me at [email protected].

Thank you very much for joining us today, John, and kicking off the conference. I'll pass it over to you.

John F. Crowley
Amicus Therapeutics, Inc. - Chairman & CEO

Great, thanks, Marty. I'll go ahead and pull up my slides, hopefully, successfully here. Can you guys see them okay?

Martin Douglas Auster;dit Suisse AG;John F. Crowley
CrÃ;Research Division - Research Analyst;Amicus

© -

Yes.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot